(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione

C98H85FN18O18 — CID 157108194

IUPAC(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione
SMILESCC(C)(C)CCOc1ccc2c(c1)CN(C[C@@]1(c3ccc(F)cc3)NC(=O)NC1=O)C2=O.O=C1NC(=O)[C@@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(O)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1
InChIInChI=1S/2C26H21N5O5.C24H26FN3O4.C22H17N5O4/c2*32-11-1-2-12-36-20-8-5-18-15-31(23(33)21(18)13-20)16-26(24(34)29-25(35)30-26)19-6-3-17(4-7-19)22-14-27-9-10-28-22;1-23(2,3)10-11-32-18-8-9-19-15(12-18)13-28(20(19)29)14-24(21(30)26-22(31)27-24)16-4-6-17(25)7-5-16;28-16-6-3-14-11-27(19(29)17(14)9-16)12-22(20(30)25-21(31)26-22)15-4-1-13(2-5-15)18-10-23-7-8-24-18/h2*3-10,13-14,32H,11-12,15-16H2,(H2,29,30,34,35);4-9,12H,10-11,13-14H2,1-3H3,(H2,26,27,30,31);1-10,28H,11-12H2,(H2,25,26,30,31)/t2*26-;24-;22-/m1000/s1
InChIKeyAGNWIWHOKNTANX-NRYBIMENSA-N
MW1821.86 g/mol
LogP7.29
Rot. Bonds22

About (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione

(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione (PubChem CID 157108194) has the molecular formula C98H85FN18O18 and a molecular weight of 1821.86 g/mol. Its IUPAC name is (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione.

Molecular Properties

Compound Name(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione
PubChem CID157108194
Molecular FormulaC98H85FN18O18
Molecular Weight1821.86 g/mol
Exact Mass1820.63
IUPAC Name(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione
SMILESCC(C)(C)CCOc1ccc2c(c1)CN(C[C@@]1(c3ccc(F)cc3)NC(=O)NC1=O)C2=O.O=C1NC(=O)[C@@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(O)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1
InChIInChI=1S/2C26H21N5O5.C24H26FN3O4.C22H17N5O4/c2*32-11-1-2-12-36-20-8-5-18-15-31(23(33)21(18)13-20)16-26(24(34)29-25(35)30-26)19-6-3-17(4-7-19)22-14-27-9-10-28-22;1-23(2,3)10-11-32-18-8-9-19-15(12-18)13-28(20(19)29)14-24(21(30)26-22(31)27-24)16-4-6-17(25)7-5-16;28-16-6-3-14-11-27(19(29)17(14)9-16)12-22(20(30)25-21(31)26-22)15-4-1-13(2-5-15)18-10-23-7-8-24-18/h2*3-10,13-14,32H,11-12,15-16H2,(H2,29,30,34,35);4-9,12H,10-11,13-14H2,1-3H3,(H2,26,27,30,31);1-10,28H,11-12H2,(H2,25,26,30,31)/t2*26-;24-;22-/m1000/s1
InChIKeyAGNWIWHOKNTANX-NRYBIMENSA-N
XLogP7.29
TPSA479.76 Ų
H-Bond Donors11
H-Bond Acceptors24
Rotatable Bonds22
Heavy Atoms135
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001821.86
LogP ≤ 57.29
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione?
The IUPAC name of (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione (CID 157108194) is (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione.
What is the SMILES notation for (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione?
The canonical SMILES for (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione is CC(C)(C)CCOc1ccc2c(c1)CN(C[C@@]1(c3ccc(F)cc3)NC(=O)NC1=O)C2=O.O=C1NC(=O)[C@@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(O)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.O=C1NC(=O)[C@](CN2Cc3ccc(OCC#CCO)cc3C2=O)(c2ccc(-c3cnccn3)cc2)N1.
What is the InChIKey of (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione?
The InChIKey is AGNWIWHOKNTANX-NRYBIMENSA-N. The full InChI is InChI=1S/2C26H21N5O5.C24H26FN3O4.C22H17N5O4/c2*32-11-1-2-12-36-20-8-5-18-15-31(23(33)21(18)13-20)16-26(24(34)29-25(35)30-26)19-6-3-17(4-7-19)22-14-27-9-10-28-22;1-23(2,3)10-11-32-18-8-9-19-15(12-18)13-28(20(19)29)14-24(21(30)26-22(31)27-24)16-4-6-17(25)7-5-16;28-16-6-3-14-11-27(19(29)17(14)9-16)12-22(20(30)25-21(31)26-22)15-4-1-13(2-5-15)18-10-23-7-8-24-18/h2*3-10,13-14,32H,11-12,15-16H2,(H2,29,30,34,35);4-9,12H,10-11,13-14H2,1-3H3,(H2,26,27,30,31);1-10,28H,11-12H2,(H2,25,26,30,31)/t2*26-;24-;22-/m1000/s1.
What are the key properties of (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione?
(5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione has a molecular weight of 1821.86 g/mol, XLogP of 7.29, 22 rotatable bonds, 11 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-5-[[6-(3,3-dimethylbutoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-fluorophenyl)imidazolidine-2,4-dione;(5S)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[[5-(4-hydroxybut-2-ynoxy)-3-oxo-1H-isoindol-2-yl]methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione;(5R)-5-[(5-hydroxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(4-pyrazin-2-ylphenyl)imidazolidine-2,4-dione is sourced from PubChem (CID 157108194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).